Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Journal of Cancer Research and Clinical Oncology
|
February 25, 2022
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
T Stolze, S Franke, J Haybaeck, et al.
Bone Marrow Transplantation
|
October 26, 2010
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
K Hübel, M M Fresen, H Salwender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
T Yoshino, G Argilés, E Oki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E Van Cutsem, M Dicato, R Geva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, E Van Cutsem, Y Narita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
E S M van Aken, B Devnani, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
F Lordick, M E Mauer, G Stocker, et al.
ESMO Open
|
June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
ESMO Open
|
February 27, 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors
E S M van Aken, S M O'Cathail, A K Gandhi, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Journal of Cancer Research and Clinical Oncology
|
February 25, 2022
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
T Stolze, S Franke, J Haybaeck, et al.
Bone Marrow Transplantation
|
October 26, 2010
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program
K Hübel, M M Fresen, H Salwender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
T Yoshino, G Argilés, E Oki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E Van Cutsem, M Dicato, R Geva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, E Van Cutsem, Y Narita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
E S M van Aken, B Devnani, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
F Lordick, M E Mauer, G Stocker, et al.
ESMO Open
|
June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
ESMO Open
|
February 27, 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors
E S M van Aken, S M O'Cathail, A K Gandhi, et al.
Page
of 12